Breakthrough study shows benefits of diagnosing hidden respiratory diseases

FHS
May 20, 2024
5:26 pm

Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical trial published in the New England Journal of Medicine.

New consortium launched to combat Mpox outbreak in Africa

University College Dublin (UCD) is leading MpoxVax AFRIVAC, a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to

October 18, 2024

Moonlake’s less-than-transparent data disclosures produced a cash windfall. Risks remain

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in

June 28, 2023

Hamas strikes could impact some biopharma operations in Israel

Several biotechs and pharma companies have issued statements clarifying the impact of Saturday’s attacks in Israel on their workers and operations. Some of the first

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.